US Researchers Develop Experimental Nanogel That Improves Memory in Alzheimer’s Models

A team of researchers from the University of South Carolina has developed an experimental nanoparticle-based system called Nano-ERASER, which shows promise in improving memory and cognitive functions in Alzheimer's disease models. The innovative approach targets a protein called PTBP1, which is crucial for maintaining the identity of astrocytes, a type of support cell in the brain.

By reducing PTBP1 levels using an intracellular degradation mechanism, the research team was able to activate a process that converts astrocytes into cells with neuronal characteristics.

The study involved both human brain organoids and mice with Alzheimer's-related characteristics. In these models, the treatment led to the recovery of processes related to learning and memory. The nanogel, designed to cross the blood-brain barrier and deliver its cargo to astrocytes, is a significant breakthrough in overcoming one of the main challenges in treating neurological diseases.

Unlike other experimental approaches that directly modify DNA, Nano-ERASER employs a non-genomic strategy, which may offer potential advantages over genetic modification methods.

The treatment was found to promote neurogenesis in the hippocampus, a brain region crucial for learning and memory, and resulted in improvements in cognitive tests in the treated mice. The researchers emphasize that these changes were not only observed at the cellular level but also accompanied by functional recovery in the animal models.

This strategy differs from traditional treatments targeting specific components of Alzheimer's pathology, as it utilizes cells already present in the brain to generate new neurons. The research combines materials engineering and regenerative medicine to create a system capable of delivering therapeutic substances directly to the brain.

While the results are promising, the Nano-ERASER treatment has not yet progressed to human trials. The preclinical findings suggest that a nanoscale system may be capable of promoting neuronal regeneration and improving cognitive functions in Alzheimer's models. However, further research is needed to determine the safety, long-term effects, and potential side effects of converting astrocytes into neurons.

The study highlights the potential of nanotechnology as a tool for targeted treatment delivery in neurodegenerative diseases, but acknowledges that significant challenges remain before the approach can be considered a viable medical treatment.